Eagles' Handling of Hurts' Clot Sparks NFL Outrage

NFL executives are reportedly furious with the Philadelphia Eagles' handling of Jalen Hurts' serious health issue. The quarterback sustained a left calf injury on October 4, 2026, during a game against the Los Angeles Rams. Following discomfort reported on October 8, an ultrasound on October 10 diagnosed a stable superficial vein thrombosis. Despite this, Eagles medical staff cleared Hurts to play in London against the Jacksonville Jaguars. Subsequent testing confirmed deep vein thrombosis and bilateral pulmonary emboli, necessitating the quarterback to go on injured reserve and miss the rest of the season.

League sources indicate that the frustration among executives is not with the medical timeline or treatment decisions, but rather with the Eagles' public messaging. Incomplete statements were issued upon Hurts' injured-reserve designation and season-ending diagnosis. This lack of transparency created controversy, requiring league officials to address the matter repeatedly. The NFL Players Association has requested a full investigation, which Commissioner Roger Goodell has welcomed, and a joint review is currently underway.

Despite the controversy, NFL Chief Medical Officer Dr. Allen Sills praised the Eagles' response, highlighting their vigilance, conservative care, and state-of-the-art imaging. He dismissed notions of external factors or physicians endangering players as "nonsense." The situation highlights ongoing concerns about player health communication as the Eagles navigate the remainder of the season without their starting quarterback.